Hackensack Meridian Mountainside Medical Center is bringing some “breakthrough technology” to its fight against breast cancer, administrators announced. (Photo: Mountainside Medical Center)
MONTCLAIR, NJ — Hackensack Meridian Mountainside Medical Center is bringing some "breakthrough technology" to its fight against breast cancer, administrators recently announced.
The hospital is purchasing two new pieces of tech, administrators said:
"MAMMOMAT Revelation, an innovative mammography system designed to overcome barriers to breast cancer detection"
"ProFound Artificial Intelligence for digital breast tomosynthesis, a deep-learning artificial intelligence software that rapidly and accurate identifies potential malignant lesions"
"We are excited to bring this breakthrough technology to our community," CEO Tim O'Brien said. "3D mammography technology provides the quality images and patient experience to make early detection possible."
To schedule a mammogram at Mountainside Medical Center, call 877-523-7787. To learn more about mammography services at the hospital, click here.
Hospital spokespeople provided the following descriptions of the new purchases:
"MAMMOMAT Revelation's 50 degree image acquisition angle results in the widest depth resolution in the market. The result is clinical detail that helps deliver high-quality 3D images helping doctors make a more confident diagnosis. High breast density can increase the risk of developing cancer. Revelation is the first mammography platform to provide automated breast density measurements during the exam, enabling immediate and personalized risk assessment, and allowing Mountainside Medical Center to provide supplemental imaging during the same appointment."
"Digital breast tomosynthesis (DBT) is a widely accepted advanced mammography technique for breast cancer screening. DBT study volumes are much larger than the standard 2D mammography, and Profound Artificial Intelligence addresses the complexities of reading DBT exams. Research shows that ProFound AI provides improved analysis and allows radiologists to read DBT studies more efficiently and consistently."
"Early detection is key when it comes to treating breast cancer," said Frank Yuppa, medical director of imaging services at Mountainside Medical Center.
Yuppa said both new purchases will be a big help toward this end.
"3D imaging makes it easier for doctors to see tumor sizes and reduces the need for patients to return for additional imaging to confirm a cancer diagnosis," Yuppa said. "This results in less patient anxiety and increased patient satisfaction."
"Integrating ProFound AI into our mammography program keeps our practice on the cutting edge and offers our patients the best chance at early detection and treatment," Yuppa added. "Streamlining and standardizing the analysis of a study with Profound Artificial Intelligence ultimately will make our mammography program more efficient."